MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 
Similar Articles
The Motley Fool
April 5, 2006
Rich Smith
Foolish Forecast: Rite Aid Writes a Script Although the retail pharmacy isn't setting the world on fire with its turnaround, its gross margins have inched up slightly over the last 18 months. Investors, take note. mark for My Articles similar articles
The Motley Fool
January 5, 2007
Matthew Crews
Rite Aid's Baby Steps If Rite Aid does manage 5% operating margins, this pharmacy chain's shares will get the love they deserve. mark for My Articles similar articles
The Motley Fool
September 22, 2010
Rich Smith
Foolish Forecast: A Prescription for Rite Aid Investors Here's what you need to know before earnings come out tomorrow. mark for My Articles similar articles
The Motley Fool
September 29, 2011
Navjot Kaur
Should You Write Off Rite Aid? Rite Aid posts a relatively better quarter as wellness rewards the company. mark for My Articles similar articles
The Motley Fool
June 25, 2007
Ryan Fuhrmann
Foolish Forecast: Rite Aid Aims for Healthy Growth The drugstore operator is set to report its first-quarter earnings. Investors, here is what you can expect to see. mark for My Articles similar articles
The Motley Fool
July 6, 2004
Alyce Lomax
Not Ready for Rite Aid Can the drugstore chain hold a candle to the competition? Its shares are trading at 22 times forward earnings, making it a seemingly less-than-advantageous time to place a bet on them. mark for My Articles similar articles
The Motley Fool
September 26, 2007
Ryan Fuhrmann
Foolish Forecast: Does Rite Aid Have the Right Rx? The retail pharmacy is set to release it second-quarter financial results. Investors, here is what you can expect to see. mark for My Articles similar articles
The Motley Fool
August 19, 2011
Ilan Moscovitz
Rite Aid Is Cheaper Than You Think Rite Aid tends to generate much more free cash flow than net income, suggesting that -- while things may not exactly be going swimmingly -- the company's stock might be a bit cheaper than many investors realize. mark for My Articles similar articles
The Motley Fool
December 11, 2006
Matthew Crews
Rite Aid: Comps Mean Competition The pharmacy chain reported positive same-store results for November. Investors, take note. mark for My Articles similar articles
The Motley Fool
June 27, 2011
Shubh Datta
All Is Not Yet Right at Rite Aid Drug retailer Rite Aid posts losses in its first fiscal quarter and sees further losses ahead. mark for My Articles similar articles
The Motley Fool
April 13, 2007
Ryan Fuhrmann
Rite Aid's Right-Size Ambitions If the retail pharmacy chain can improve its net margins, reduce debt, and smoothly integrate its latest acquisition, the stock's upside would be substantial. mark for My Articles similar articles
The Motley Fool
June 29, 2007
Ryan Fuhrmann
Rite Aid's Recent Remedy Will increased market clout lead the drugstore operator to new highs? Investors, take note. mark for My Articles similar articles
The Motley Fool
September 27, 2007
Ryan Fuhrmann
Rite Aid Looks a Little Peaked Bigger doesn't necessarily mean better for the drugstore retailer; it has quite a bit of work to do to convince investors it can successfully manage the empire that it has acquired. mark for My Articles similar articles
The Motley Fool
April 11, 2008
Ryan Fuhrmann
Rite Aid Hasn't Fully Recovered Rite Aid needs to be nursed back to health after its acquisition of Brooks Eckerd. mark for My Articles similar articles
The Motley Fool
June 22, 2006
Stephen D. Simpson
Rite Aid: Not Quite Rad, but Not All Bad Better results are possible, but there might be better ideas for investors. mark for My Articles similar articles
The Motley Fool
September 22, 2005
Stephen D. Simpson
Rite Aid Not Right Yet The bleeding seems to have stopped at this pharmacy, but recovery could be a long and slow road. Intrepid, not to mention patient, investors may see potential here, but there are far better turnaround ideas to be had. mark for My Articles similar articles
The Motley Fool
June 25, 2004
Steven Mallas
Rite Aid in the Shadows The first quarter for Rite Aid, the pharmaceutical retailer, shows a profit, but is it time to add this stock to your portfolio? mark for My Articles similar articles
The Motley Fool
October 4, 2005
Seth Jayson
Same Old Same-Store Story Reports from Walgreen and Rite Aid confirm the obvious. Investors will nearly always do better buying the best company in any given space. mark for My Articles similar articles
The Motley Fool
September 25, 2009
Chris Jones
The First Symptom of Health-Care Troubles? Rite Aid's problems imply bad news for consumers and the health-care system. mark for My Articles similar articles
The Motley Fool
January 3, 2012
Shubh Datta
Bright Spots for Rite Aid Better same-store sales help Rite Aid trim losses. mark for My Articles similar articles
The Motley Fool
September 29, 2011
Dan Caplinger
Has Rite Aid Become the Perfect Stock? The company needs to turn itself around first before anyone will seriously expect superior results from Rite Aid. mark for My Articles similar articles
The Motley Fool
June 11, 2007
Mike Cianciolo
Rite Aid's Generic Sales The drugstore chain gradually increases sales, and catches up to the big boys in one way. Investors, take note. mark for My Articles similar articles
The Motley Fool
March 8, 2005
Seth Jayson
Rite Aid Wretched? Value investors may be interested in Rite Aid. mark for My Articles similar articles
The Motley Fool
March 29, 2006
Rich Smith
Foolish Forecast: Stride Rite Laces Up Investors may want to look past the slew of one-time, non-cash charges to GAAP earnings due to the Saucony acquisition and focus on cash profitability instead when the company reports its fiscal first-quarter 2006 numbers. mark for My Articles similar articles
The Motley Fool
May 9, 2006
Rich Smith
Foolish Forecast: TOM on the Line TOM Online, one of China's leading Internet portals and wireless service providers, reports its first-quarter 2006 earnings numbers tomorrow. mark for My Articles similar articles
The Motley Fool
January 3, 2005
Nathan Slaughter
Walgreen Seeing Green Rivals CVS and Rite Aid have a bitter pill to swallow as Walgreen stays strong. While Walgreen's revenues were in line with forecasts, the stronger-than-expected bottom line has the stock gaining ground. mark for My Articles similar articles
The Motley Fool
March 20, 2006
Rich Smith
Foolish Forecast: Progress Boots Up Over the past four years, application infrastructure software maker Progress has beaten consensus estimates for its earnings 15 times in a row. Can the company make it a streak of "sweet 16" trouncings of the Wall Street Wise? mark for My Articles similar articles
The Motley Fool
December 19, 2011
Seth Jayson
Golf Clap for Rite Aid Rite Aid reported revenue of $6.3 billion. The five analysts polled by S&P Capital IQ looked for revenue of $6.3 billion. mark for My Articles similar articles
The Motley Fool
January 4, 2005
Seth Jayson
Rite Aid Still Needs First Aid Sales keep slacking for this tough turnaround. This doesn't mean investors should necessarily jump ship. mark for My Articles similar articles
The Motley Fool
September 22, 2006
Ryan Fuhrmann
More in Store at Rite Aid? The retail pharmacy posted strong second-quarter sales, and an acquisition could help long-term results. Investors, take note. mark for My Articles similar articles
The Motley Fool
May 22, 2006
Rich Smith
Foolish Forecast: Trying on Perry Ellis The clothier reports first-quarter 2007 earnings results tomorrow. Want to know what Wall Street expects to see? Want to know what really matters? Investors, take note. mark for My Articles similar articles
The Motley Fool
January 31, 2006
Rich Smith
Foolish Forecast: Knocking Over drugstore.com Like to invest in companies that lose money? Then online drug retailer drugstore.com is one for you. Over its history, it has racked up losses totaling $732.8 million. mark for My Articles similar articles
The Motley Fool
April 3, 2006
Rich Smith
Foolish Forecast: Delta & Pine Land When considering this farming company's margin trends, it's best for investors to focus on rolling gross and operating margins and be leery of drawing conclusions from the net results. mark for My Articles similar articles
The Motley Fool
January 25, 2006
Rich Smith
Foolish Forecast: 1-800-Flowers in Season In its fiscal first-quarter earnings release back in November, the company promised improved margins later in the year. Investors, don't expect to see the whole bump all at once. mark for My Articles similar articles
The Motley Fool
July 17, 2006
Rich Smith
Foolish Forecast: The Real United Technologies? When the conglomerated defense contractor reports its fiscal second-quarter 2006 results early tomorrow morning, will it revert to the past, or continue wowing the critics? mark for My Articles similar articles
The Motley Fool
February 22, 2006
Rich Smith
Foolish Forecast: Pushing the Limited Judging from the rolling margins, the company appears to be slipping, becoming less profitable over time, and thus unlikely to turn in a profits improvement three times better than its sales improvement. Investors, take note. mark for My Articles similar articles
The Motley Fool
March 15, 2006
Rich Smith
Foolish Forecast: New York, New Year Analysts are looking for clothier New York & Co. to hit the top of its latest guidance of $0.33 to $0.36 per share for the quarter. That 9% increase might be a bit optimistic, however, in light of the already confirmed "revenue miss." mark for My Articles similar articles
The Motley Fool
November 23, 2008
Todd Wenning
A Value Stock to Avoid in This Market Rite Aid is one "value" to avoid in this market. mark for My Articles similar articles
The Motley Fool
January 30, 2006
Rich Smith
Foolish Forecast: American Standard American Standard's gross margin, which wasn't impacted at all by restructuring charges, has remained strong -- even growing slightly. Investors, take note. mark for My Articles similar articles
The Motley Fool
June 28, 2007
Anders Bylund
Righteous Profits for Rite Aid: Fool by Numbers The drugstore chain released first-quarter 2008 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
December 6, 2006
Rich Smith
Foolish Forecast: Should You Believe in Credence? When the semiconductor tester reports its fourth-quarter and full-year 2006 earnings, will this make for three quarters in a row of missing analyst projections? Investors, take note. mark for My Articles similar articles
The Motley Fool
June 20, 2006
Rich Smith
Foolish Forecast: Marking the Finish Line The footwear retailer is scheduled to report its fiscal first-quarter 2007 earnings numbers tomorrow after close of trading. Investors, want to know what Wall Street expects to see? Want to know what really matters? mark for My Articles similar articles
The Motley Fool
July 18, 2006
Rich Smith
Foolish Forecast: General Dynamics Forms Ranks The defense contracting powerhouse reports its second-quarter earnings results early tomorrow. Investors, take note. mark for My Articles similar articles
The Motley Fool
December 16, 2004
Nathan Slaughter
Rx: Get Some Earnings Quick The No. 3 drug chain Rite Aid posts a sharp drop in earnings and slashes guidance again. mark for My Articles similar articles
The Motley Fool
March 9, 2004
Alyce Lomax
February Frenzy at CVS, Rite Aid The flu season's early end hasn't stopped drugstore retailers. mark for My Articles similar articles
The Motley Fool
March 14, 2006
Rich Smith
Foolish Forecast: Charmed, I'm Sure Should investors like this chain of plus-sized women's clothing stores? mark for My Articles similar articles
The Motley Fool
June 24, 2005
Stephen D. Simpson
Is Rite Aid a Real Value Stock? Reality hasn't caught up with the company's turnaround prospects. Rite Aid must deal with a lot of debt and preferred equity if and when it recovers. mark for My Articles similar articles
The Motley Fool
April 6, 2006
Stephen D. Simpson
Rite Aid Regains Respectability The pharmacy's slow, steady turnaround may not be enough. There have been so many dilutive financing events that it's no longer clear whether common equity shareholders will gain enough bang to compensate for the risk. mark for My Articles similar articles
The Motley Fool
February 6, 2006
Rich Smith
Foolish Forecast: Under Armour Undresses Under Armour's short history doesn't tell investors much more than that gross margins are strengthening -- a strength that hasn't yet dropped to the bottom line. mark for My Articles similar articles
The Motley Fool
March 15, 2006
Rich Smith
Foolish Forecast: Pricing Cost Plus How do rising sales turn into falling profits? Sadly, that's exactly what's going on at Cost Plus. Investors, take note. mark for My Articles similar articles